This report studies Cancer/Tumor Profiling in Global and China market, focuses on top manufacturers in global and China market, involving Cancer/Tumor Profiling price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of Cancer/Tumor Profiling in USA, EU, China, Japan, India and Southeast Asia, forecast to 2020, from 2011.
The global cancer/tumor profiling market is estimated to grow at a CAGR of 17.5%, to reach approximately $45 billion by 2020. North America accounts for the largest share of this market, followed by Europe. The large shares of the North American and European region can be attributed to the presence of technology providers, availability of better R&D facilities, and promising funding landscape. Emerging economics such as China, India, Japan, and other regions in Asia-Pacific and the untapped markets in Europe are expected to witness significant growth in the future. The growth in these regions will be propelled by a number of factors such as growing GDP, increasing healthcare costs, and rising demand for safe and cost-effective diagnostics and therapeutics.
Split by product types, with production, revenue, market share and price of each type, as well as the types and price of each type price for each manufacturer in 2015 and 2016, through interviewing the key manufacturers, covering
Split by manufacturers, this report focuses on the production, price of each type, average price of Cancer/Tumor Profiling, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering
Caris Life Sciences
Proteome Sciences PLC
Boreal Genomics, Inc
Oxford Gene Technology Ltd
Split by applications, this report focuses on consumption and growth rate of Cancer/Tumor Profiling in each application, can be divided into
Split by regions, this report focuses on the production, revenue, consumption and market share of Cancer/Tumor Profiling in these regions, from 2011 to 2020 (forecast), covering